Karla Santos da Costa Rosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karla Santos da Costa Rosa has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
- Livia Costa de Oliveira
GPQual—Palliative Care and Quality of Life Research Group, Barretos Cancer Hospital, São Paulo, Brazil
15 shared publications - Emanuelly Varea Maria Wiegert
Palliative Care Unit, National Cancer Institute, Rio de Janeiro, RJ, Brazil
4 shared publications Livia Costa de Oliveira
3 shared publications- Simone Garruth dos Santos Machado Sampaio
Doutora. Médica. Unidade de Cuidados Paliativos do Hospital do Câncer IV (HC IV) do Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Rio de Janeiro (RJ), Brasil
3 shared publications Ana Luísa Durante
2 shared publications- Anke Bergmann
Department of Human Genetics, Hannover Medical School, Hannover, Germany
2 shared publications
Latest Publications
- Open Access
- 26 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1020
Low handgrip strength in advanced cancer: associated factors and clinical implications in palliative care
Introduction: Handgrip strength (HGS) is a widely used clinical and prognostic tool in oncology and is associated with several outcomes in palliative care (PC). Objective: To evaluate the factors associated with low HGS in patients with advanced cancer receiving PC. Methods: A cross-sectional study was conducted at the Brazilian National Cancer Institute between 2023 and 2025, including patients with advanced cancer receiving PC. HGS was measured using a Jamar® hydraulic dynamometer. HGS values below the first tertile were classified as low HGS. Clinical, sociodemographic, functional, and nutritional data were collected. Analyses, stratified by sex, included logistic regression, with odds ratios (ORs) and 95% confidence intervals (CI) as estimators. Results: Five hundred twenty-seven patients were included, with a median age of 66 years, predominantly women (58%), and with primary tumor sites in the gastrointestinal tract (24%) and gynecological (21%). The cutoff points defining low HGS (1 st tertiles) were: ≤ 12 kg for women and ≤ 20 kg for men. A higher risk of low HGS was observed among older women (OR: 2.29; 95% CI: 1.31–4.01) and those with Karnofsky Performance Status (KPS) 40–50% (OR: 5.06; 95% CI: 3.01–8.49); as well as among older men (OR: 4.02; 95% CI: 2.36–8.35) and those with KPS 40–50% (OR: 3.89; 95% CI: 2.52–6.34). Conclusion: Advanced age and lower KPS were independently associated with low HGS in patients with advanced cancer receiving palliative care. These findings support HGS as an objective indicator of physical vulnerability in this population.
- 26 September 2026
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 34 (10) , 1020
Open AccessLow handgrip strength in advanced cancer: associated factors and clinical implications in palliative care
Introduction: Handgrip strength (HGS) is a widely used clinical and prognostic tool in oncology and is associated with several outcomes in palliative care (PC). Objective: To evaluate the factors associated with low HGS in patients with advanced cancer receiving PC. Methods: A cross-sectional study was conducted at the Brazilian National Cancer Institute between 2023 and 2025, including patients with advanced cancer receiving PC. HGS was measured using a Jamar® hydraulic dynamometer. HGS values below the first tertile were classified as low HGS. Clinical, sociodemographic, functional, and nutritional data were collected. Analyses, stratified by sex, included logistic regression, with odds ratios (ORs) and 95% confidence intervals (CI) as estimators. Results: Five hundred twenty-seven patients were included, with a median age of 66 years, predominantly women (58%), and with primary tumor sites in the gastrointestinal tract (24%) and gynecological (21%). The cutoff points defining low HGS (1 st tertiles) were: ≤ 12 kg for women and ≤ 20 kg for men. A higher risk of low HGS was observed among older women (OR: 2.29; 95% CI: 1.31–4.01) and those with Karnofsky Performance Status (KPS) 40–50% (OR: 5.06; 95% CI: 3.01–8.49); as well as among older men (OR: 4.02; 95% CI: 2.36–8.35) and those with KPS 40–50% (OR: 3.89; 95% CI: 2.52–6.34). Conclusion: Advanced age and lower KPS were independently associated with low HGS in patients with advanced cancer receiving palliative care. These findings support HGS as an objective indicator of physical vulnerability in this population.
- Open Access
- 3 September 2026
- Published by Elsevier in Clinical Nutrition
- Vol. 66
Nutritional screening and recommendations for patients with incurable cancer in palliative care: Delphi study
- 3 September 2026
- Published by Elsevier in Clinical Nutrition
- Vol. 66
Open AccessNutritional screening and recommendations for patients with incurable cancer in palliative care: Delphi study
- Open Access
- 6 August 2026
- Published by Wiley in Scandinavian Journal of Caring Sciences
- Vol. 40 (3) , e70303
Content Validation of Primary Care Network Assessment Scale for Palliative Care Patients ( ARCP ) and Clinical Utility in Patients With Advanced Cancer
Objective: To validate the content of Primary Care Network Assessment Scale for Palliative Care Patients (ARCP) and to assess its clinical utility in patients with advanced cancer. Methods: This methodological study was conducted in two phases. Phase 1 involved content validation by ten social work experts using the Content Validity Index (CVI). Phase 2 evaluated clinical utility in a cross‐sectional study of 148 patients with advanced cancer receiving palliative care. Data included sociodemographic and clinical variables, global quality of life (EORTC QLQ‐C15‐PAL) and perceived social support (SSQ6). Multivariate logistic regression analyses were performed. Results: The ARCP showed high content validity, with CVI values above 0.80 for relevance, clarity and vocabulary across all items. Clinically, 80% of patients were classified as having fully participatory caregiving networks; however, 42% relied on a single caregiver, indicating structural vulnerability despite high perceived support. Male sex (OR = 2.53; 95% CI: 1.02–4.34), being married (OR = 2.78; 95% CI: 1.06–7.29), better global quality of life (OR = 2.33; 95% CI: 1.08–2.57) and greater satisfaction with social support (OR = 5.41; 95% CI: 1.35–15.05) were independently associated with a fully participatory network. Conclusion: The ARCP demonstrated evidence of content validity and clinical utility for assessing caregiving network structure in palliative care.
- 6 August 2026
- Published by Wiley in Scandinavian Journal of Caring Sciences
- Vol. 40 (3) , e70303
Open AccessContent Validation of Primary Care Network Assessment Scale for Palliative Care Patients ( ARCP ) and Clinical Utility in Patients With Advanced Cancer
Objective: To validate the content of Primary Care Network Assessment Scale for Palliative Care Patients (ARCP) and to assess its clinical utility in patients with advanced cancer. Methods: This methodological study was conducted in two phases. Phase 1 involved content validation by ten social work experts using the Content Validity Index (CVI). Phase 2 evaluated clinical utility in a cross‐sectional study of 148 patients with advanced cancer receiving palliative care. Data included sociodemographic and clinical variables, global quality of life (EORTC QLQ‐C15‐PAL) and perceived social support (SSQ6). Multivariate logistic regression analyses were performed. Results: The ARCP showed high content validity, with CVI values above 0.80 for relevance, clarity and vocabulary across all items. Clinically, 80% of patients were classified as having fully participatory caregiving networks; however, 42% relied on a single caregiver, indicating structural vulnerability despite high perceived support. Male sex (OR = 2.53; 95% CI: 1.02–4.34), being married (OR = 2.78; 95% CI: 1.06–7.29), better global quality of life (OR = 2.33; 95% CI: 1.08–2.57) and greater satisfaction with social support (OR = 5.41; 95% CI: 1.35–15.05) were independently associated with a fully participatory network. Conclusion: The ARCP demonstrated evidence of content validity and clinical utility for assessing caregiving network structure in palliative care.
- Open Access
- 25 June 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 71 (4)
Padrões de Tratamento das Neoplasias Invasivas no Sistema Único de Saúde no Período de 2000 a 2019
Introdução: Diferentes tratamentos podem ser utilizados para o enfrentamento do câncer. Objetivo: Analisar os padrões de tratamento de pacientes diagnosticados com os seis tipos mais comuns de câncer invasivo no Brasil e atendidos no Sistema Único de Saúde. Método: Análise transversal com dados extraídos do Módulo Integrador dos Registros Hospitalares de Câncer sobre pacientes diagnosticados com os cânceres de mama feminino, próstata, colorretal, pulmão, estômago e colo do útero de 2000 a 2019. Para análise dos dados foi utilizado o teste qui-quadrado e o tamanho do efeito. Resultados: Foram incluídos dados de 1.204.222 pacientes. A cirurgia foi o tratamento mais frequente nos casos diagnosticados precocemente, destacando-se os casos de câncer de próstata (87,5%) e colorretal (56,1%). Para cânceres em estádio avançado, predominou a quimioterapia, principalmente em pulmão (88,2%) e mama (48,3%). A importância do estadiamento clínico no diagnóstico para a tomada de decisão terapêutica foi identificada em todos os tipos de câncer, principalmente em relação à cirurgia e quimioterapia. Variáveis como idade, escolaridade, cor da pele, Região de residência e nível de acreditação do serviço impactaram os padrões de tratamento. Conclusão: Este estudo mostrou que o estádio avançado do câncer no momento do diagnóstico foi o principal definidor do modo de tratamento recebido. Desigualdades sociodemográficas também influenciaram o acesso às diferentes opções terapêuticas.
- 25 June 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 71 (4)
Open AccessPadrões de Tratamento das Neoplasias Invasivas no Sistema Único de Saúde no Período de 2000 a 2019
Introdução: Diferentes tratamentos podem ser utilizados para o enfrentamento do câncer. Objetivo: Analisar os padrões de tratamento de pacientes diagnosticados com os seis tipos mais comuns de câncer invasivo no Brasil e atendidos no Sistema Único de Saúde. Método: Análise transversal com dados extraídos do Módulo Integrador dos Registros Hospitalares de Câncer sobre pacientes diagnosticados com os cânceres de mama feminino, próstata, colorretal, pulmão, estômago e colo do útero de 2000 a 2019. Para análise dos dados foi utilizado o teste qui-quadrado e o tamanho do efeito. Resultados: Foram incluídos dados de 1.204.222 pacientes. A cirurgia foi o tratamento mais frequente nos casos diagnosticados precocemente, destacando-se os casos de câncer de próstata (87,5%) e colorretal (56,1%). Para cânceres em estádio avançado, predominou a quimioterapia, principalmente em pulmão (88,2%) e mama (48,3%). A importância do estadiamento clínico no diagnóstico para a tomada de decisão terapêutica foi identificada em todos os tipos de câncer, principalmente em relação à cirurgia e quimioterapia. Variáveis como idade, escolaridade, cor da pele, Região de residência e nível de acreditação do serviço impactaram os padrões de tratamento. Conclusão: Este estudo mostrou que o estádio avançado do câncer no momento do diagnóstico foi o principal definidor do modo de tratamento recebido. Desigualdades sociodemográficas também influenciaram o acesso às diferentes opções terapêuticas.
- Open Access
Go Wish Card Game for Meaningful Conversations in the Oncology Healthcare Context: A Narrative Review
The Go Wish Card Game (GWCG) is emerging as a valuable tool for facilitating end-of-life (EoL) discussions, particularly in oncology care where patients face complex treatment decisions. This review investigates the GWCG’s intended use, its application in oncology settings, and best practices for introducing it to patients. It also addresses the challenges and barriers to its implementation in clinical practice. A search for scientific evidence revealed a significant gap in the literature: while various sources, including qualitative studies and reviews, were reviewed, only a small portion focused on intervention outcomes. This underscores the need for more comprehensive studies to evaluate the GWCG’s effectiveness, especially in EoL care. Despite its potential to foster meaningful conversations and support informed decision-making, successful implementation requires overcoming barriers such as patient resistance and the need for a sensitive, gradual approach to EoL topics. Further research, particularly clinical trials, is essential to confirm its broader applicability and effectiveness.
Open AccessGo Wish Card Game for Meaningful Conversations in the Oncology Healthcare Context: A Narrative Review
The Go Wish Card Game (GWCG) is emerging as a valuable tool for facilitating end-of-life (EoL) discussions, particularly in oncology care where patients face complex treatment decisions. This review investigates the GWCG’s intended use, its application in oncology settings, and best practices for introducing it to patients. It also addresses the challenges and barriers to its implementation in clinical practice. A search for scientific evidence revealed a significant gap in the literature: while various sources, including qualitative studies and reviews, were reviewed, only a small portion focused on intervention outcomes. This underscores the need for more comprehensive studies to evaluate the GWCG’s effectiveness, especially in EoL care. Despite its potential to foster meaningful conversations and support informed decision-making, successful implementation requires overcoming barriers such as patient resistance and the need for a sensitive, gradual approach to EoL topics. Further research, particularly clinical trials, is essential to confirm its broader applicability and effectiveness.
- 19 July 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (e3) , e924-e927
Quality of death educational programme in a national reference palliative care unit
Objective To report the experience of offering the Quality End of Life Care for All (QELCA) Programme, highlighting the distinct methodology for the training of health professionals. Development The QELCA Programme, intellectual property of St Christopher’s Hospice, was offered to seven health professionals working in the hospital palliative care unit at the National Cancer Institute, between June and December 2022, with the support of Premier Institute. The programme, which originates in the UK, has been evaluated there and is currently being evaluated in Hong Kong, and is delivered in two phases: (1) a 5-day immersion programme; (2) monthly sessions of Action Learning for 6 months. Participants realised that communication between members of the multidisciplinary team, as well as between health professionals and patients/loved ones, was one of the key challenges for achieving quality of death in the hospital palliative care unit. This insight empowered them to drive forward significant changes in practice that promise to improve quality of care. Conclusion The QELCA Programme enabled participants to engage in active problem-solving to promote the relief of suffering of patients and their families in end-of-life care.
- 19 July 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 13 (e3) , e924-e927
Quality of death educational programme in a national reference palliative care unit
Objective To report the experience of offering the Quality End of Life Care for All (QELCA) Programme, highlighting the distinct methodology for the training of health professionals. Development The QELCA Programme, intellectual property of St Christopher’s Hospice, was offered to seven health professionals working in the hospital palliative care unit at the National Cancer Institute, between June and December 2022, with the support of Premier Institute. The programme, which originates in the UK, has been evaluated there and is currently being evaluated in Hong Kong, and is delivered in two phases: (1) a 5-day immersion programme; (2) monthly sessions of Action Learning for 6 months. Participants realised that communication between members of the multidisciplinary team, as well as between health professionals and patients/loved ones, was one of the key challenges for achieving quality of death in the hospital palliative care unit. This insight empowered them to drive forward significant changes in practice that promise to improve quality of care. Conclusion The QELCA Programme enabled participants to engage in active problem-solving to promote the relief of suffering of patients and their families in end-of-life care.
- Open Access
- 7 March 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 31, 1-10
Cancer patients with COVID-19: does prior nutritional risk associated with cancer indicate a poor prognosis for COVID-19?
Highlights Patients at nutritional risk had a lower survival than those not at nutritional risk. Nutritional risk had good discriminatory accuracy to predict death. Nutritional screening should be included as an essential part of care for these patients. ABSTRACT Objective To verify whether the presence of related nutritional risk indicators prior to COVID-19 diagnosis is associated with poor survival in patients with cancer. Methods We retrospectively analyzed the data of hospitalized cancer patients who tested positive for COVID-19 between
- 7 March 2023
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 31, 1-10
Open AccessCancer patients with COVID-19: does prior nutritional risk associated with cancer indicate a poor prognosis for COVID-19?
Highlights Patients at nutritional risk had a lower survival than those not at nutritional risk. Nutritional risk had good discriminatory accuracy to predict death. Nutritional screening should be included as an essential part of care for these patients. ABSTRACT Objective To verify whether the presence of related nutritional risk indicators prior to COVID-19 diagnosis is associated with poor survival in patients with cancer. Methods We retrospectively analyzed the data of hospitalized cancer patients who tested positive for COVID-19 between
- 21 February 2023
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (2) , 485-499
Proposal of a nutrition screening algorithm for patients with incurable cancer receiving palliative care: Data from a prospective cohort
Objective: To propose and evaluate the clinical utility of a new nutrition screening algorithm, NutriPal, to detect the degree of nutritional risk in patients with incurable cancer receiving palliative care.Methods: It is a prospective cohort conducted in an oncology palliative care unit. The NutriPal algorithm was used in a three‐step process: (i) administration of the Patient‐Generated Subjective Global Assessment short form; (ii) calculation of the Glasgow Prognostic Score; and (iii) application of the algorithm to classify patients into four degrees of nutritional risk. The higher the degrees of NutriPal, the worse the nutritional risk, comparing nutritional measures, laboratory data, and overall survival (OS).Results: The study included 451 patients that were classified using the NutriPal. They were allocated to the degrees: 1 (31.26%), 2 (27.49%), 3 (21.73%), and 4 (19.71%). Statistically significant differences were found in most of the nutritional and laboratory parameters and in OS with each increment in the NutriPal degrees, and OS was reduced (log‐rank <0.001). In addition, NutriPal was able to predict a 120‐day mortality: there was a significantly higher risk of death in the patients classified as degrees 4 (hazard ratio [HR], 3.03; 95% confidence interval [95% CI], 2.18–4.19), 3 (HR, 2.01; 95% CI, 1.46–2.78), and 2 (HR, 1.42; 95% CI; 1.04–1.95) than in those classified as degree 1. It also showed good predictive accuracy (concordance statistic, 0.76).Conclusion: The NutriPal is associated to nutritional and laboratory parameters and can predict survival. It could therefore be incorporated into clinical practice for patients with incurable cancer receiving palliative care.
- 21 February 2023
- Published by Wiley in Nutrition in Clinical Practice
- Vol. 39 (2) , 485-499
Proposal of a nutrition screening algorithm for patients with incurable cancer receiving palliative care: Data from a prospective cohort
Objective: To propose and evaluate the clinical utility of a new nutrition screening algorithm, NutriPal, to detect the degree of nutritional risk in patients with incurable cancer receiving palliative care.Methods: It is a prospective cohort conducted in an oncology palliative care unit. The NutriPal algorithm was used in a three‐step process: (i) administration of the Patient‐Generated Subjective Global Assessment short form; (ii) calculation of the Glasgow Prognostic Score; and (iii) application of the algorithm to classify patients into four degrees of nutritional risk. The higher the degrees of NutriPal, the worse the nutritional risk, comparing nutritional measures, laboratory data, and overall survival (OS).Results: The study included 451 patients that were classified using the NutriPal. They were allocated to the degrees: 1 (31.26%), 2 (27.49%), 3 (21.73%), and 4 (19.71%). Statistically significant differences were found in most of the nutritional and laboratory parameters and in OS with each increment in the NutriPal degrees, and OS was reduced (log‐rank <0.001). In addition, NutriPal was able to predict a 120‐day mortality: there was a significantly higher risk of death in the patients classified as degrees 4 (hazard ratio [HR], 3.03; 95% confidence interval [95% CI], 2.18–4.19), 3 (HR, 2.01; 95% CI, 1.46–2.78), and 2 (HR, 1.42; 95% CI; 1.04–1.95) than in those classified as degree 1. It also showed good predictive accuracy (concordance statistic, 0.76).Conclusion: The NutriPal is associated to nutritional and laboratory parameters and can predict survival. It could therefore be incorporated into clinical practice for patients with incurable cancer receiving palliative care.